SIRPant Immunotherapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch SIRPant Immunotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT05967416) | SIRPant Immunotherapeutics, Inc. | 2024-01-17 |
Track SIRPant Immunotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.